Abstract A panel of Italian neurologists of the Italian Society for the study of Dementias (SINDEM) discussed the recently proposed new lexicon for Alzheimer disease (AD) and the related diagnostic criteria for the different phases of the disease (Preclinical AD, prodromal AD and Alzheimer's dementia) (Dubois et al. in Lancet Neurol 6:734-746, 2007; in Lancet Neurol 9:1118-1127, 2010). The aim of this discussion was to reach a consensus, among the Italian neurologists involved in the study and care of persons with dementia, in particular in reference to the potential use of the proposed diagnostic criteria in clinical practice. After having critically revised the scientific evidence related to the new lexicon and to the new proposed diagno...
Dementia is a clinical state with many different causes,characterized by a decline from a previously...
Background and purpose: Biomarkers support the aetiological diagnosis of neurocognitive disorders in...
We conducted a survey regarding the medical care of patients with dementia in expert settings in Bel...
Abstract A panel of Italian neurologists of the Italian Society for the study of Dementias (SINDEM)...
A panel of Italian neurologists of the Italian Society for the study of Dementias (SINDEM) discussed...
Alzheimer's disease (AD) is classically defined as a dual clinicopathological entity. The recent adv...
none19No.Risultati originali pubblicati su una rivista, le cui norme editoriali prevedono che anche ...
The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of...
We conducted a survey regarding the medical care of patients with dementia in expert settings in Bel...
Criteria for the diagnosis of Alzheimer’s disease were established in 1984 by the National Institute...
International audienceThe New Criteria for the diagnosis of Alzheimer’s disease (AD), published by a...
Biomarkers of brain amyloidosis and neurodegeneration/synaptic dysfunction are featured in recent di...
Dementia is a clinical state with many different causes,characterized by a decline from a previously...
Background and purpose: Biomarkers support the aetiological diagnosis of neurocognitive disorders in...
We conducted a survey regarding the medical care of patients with dementia in expert settings in Bel...
Abstract A panel of Italian neurologists of the Italian Society for the study of Dementias (SINDEM)...
A panel of Italian neurologists of the Italian Society for the study of Dementias (SINDEM) discussed...
Alzheimer's disease (AD) is classically defined as a dual clinicopathological entity. The recent adv...
none19No.Risultati originali pubblicati su una rivista, le cui norme editoriali prevedono che anche ...
The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of...
We conducted a survey regarding the medical care of patients with dementia in expert settings in Bel...
Criteria for the diagnosis of Alzheimer’s disease were established in 1984 by the National Institute...
International audienceThe New Criteria for the diagnosis of Alzheimer’s disease (AD), published by a...
Biomarkers of brain amyloidosis and neurodegeneration/synaptic dysfunction are featured in recent di...
Dementia is a clinical state with many different causes,characterized by a decline from a previously...
Background and purpose: Biomarkers support the aetiological diagnosis of neurocognitive disorders in...
We conducted a survey regarding the medical care of patients with dementia in expert settings in Bel...